-
公开(公告)号:EP3858832A1
公开(公告)日:2021-08-04
申请号:EP19878278.1
申请日:2019-10-29
发明人: LIU, Fei , FENG, Weiwei , WANG, Bin , XU, Hongjiang , WANG, Jinan , ZHANG, Xiquan , WANG, Shanchun , LIU, Yanlong , ZHANG, Jianqing , YAO, Yiyan , TANG, Xujing , SHI, Wei , ZHANG, Hongying , LI, Yang , TANG, Song , ZHU, Yizhong , LIU, Limin , GU, Hongmei , YANG, Ling
IPC分类号: C07D471/04 , C07D211/96 , C07D215/20 , A61K31/404 , A61P35/00
摘要: Disclosed is a trifluoromethyl-substituted sulfonamide BCL-2-selective inhibitor, in particular disclosed are a compound of formula I, a stereoisomer or a pharmaceutically acceptable salt thereof, a preparation method therefor, and a pharmaceutical composition thereof. Also disclosed are the uses of said compound and of a pharmaceutical composition comprising same for treating anti-apoptotic BCL-2-related diseases, such as cancer.
-
2.
公开(公告)号:EP3978494A1
公开(公告)日:2022-04-06
申请号:EP20813454.4
申请日:2020-05-22
发明人: LIU, Fei , LIU, Yanlong , XU, Hongjiang , ZHANG, Xiquan , WANG, Shanchun , ZHANG, Jianqing , FENG, Weiwei , WANG, Bin , WANG, Jinan , WANG, Yubing , TANG, Xujing , NIE, Quandeng
IPC分类号: C07D471/04 , C07D211/96 , C07D215/20 , A61K31/404 , A61P35/00
摘要: Disclosed is a methyl- and trifluoromethyl-containing disubstituted sulfonamide selective BCL-2 inhibitor; specifically disclosed are a compound of formula I, a stereoisomer or pharmaceutically acceptable salt of same, a preparation method therefor, and a pharmaceutical composition comprising the compound. Also disclosed are uses of the compound and of the pharmaceutical composition comprising the compound in treating anti-apoptotic protein BCL-2-related diseases such as cancer.
-
公开(公告)号:EP4289833A1
公开(公告)日:2023-12-13
申请号:EP22749196.6
申请日:2022-01-30
发明人: LIU, Fei , LIU, Yanlong , WANG, Bin , XU, Hongjiang , TANG, Xujing
IPC分类号: C07D401/12 , C07D401/14 , C07D403/12 , C07D403/14 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14 , A61K31/501 , A61P29/00 , A61P37/00
摘要: A TYK2 inhibitor compound containing a bicyclic ring and the use thereof in the preparation of a drug for treating or preventing TYK2-related diseases.
-
-